[178] analyzed “The role of NPC1L1 in cancer” and concluded that NPC1L1 knockdown significantly reduces the levels of inflammatory markers such as pc‐Jun, p‐ERK, and caspase‐1 p20 in CRC. This evidence concerns the gene NPC1L1 and colorectal carcinoma.